However, MRD positivity with CD19+ blasts persisted, and the disease later relapsed as CD19+ B-ALL with concurrent myeloid sarcoma harboring KMT2A rearrangement in the thoracic spinal cord. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.